The AMCP Format has become the gold standard for communicating the clinical and economic value of drugs, tests, and devices to healthcare decision makers. Version 4.0 is the newest iteration of the Format , last updated in 2012. An understanding of the Format is central for dossier developers to produce a dossier that meets the evidentiary requirements for formulary consideration in a transparent manner and also promotes a meaningful dialogue between manufacturers and healthcare decision makers.
Join our featured speakers, Evelyn Sarnes and Kim Boswell, for a complimentary webinar focusing on key updates to the Format , version 4.0. Additionally, the speakers will share guidance as provided in the AMCP Format in regard to special content considerations (eg, comparative effectiveness research, companion diagnostic tests, and biosimilars) as well as logistical considerations with regard to AMCP dossiers.
Benefits Include :
- Understand core content requirements for each section of the dossier per updated AMCP Format , version 4.0
- Gain insights on additional guidance considerations provided by the Format
Evelyn Sarnes, PharmD, MPH, Senior Director Medical Communications, Xcenda
Evelyn Sarnes, PharmD, MPH, is a Senior Director and leads the Medical Communications Team in Global Health Economics and Outcomes Research(GHEOR) Scientific Consulting at Xcenda. In this role, she leads HEOR engagements including development and strategic review of Academy of Managed Care Pharmacy (AMCP) Formulary dossiers, global value dossiers, comparative effectiveness research studies, systematic literature reviews, and scientific publications. Dr. Sarnes also has expertise in designing and developing managed markets strategy and tools, and in gathering payer insights to inform both market access and HEOR initiatives and tactics. Dr. Sarnes’ experience ranges across multiple therapeutic areas, including specialty Pharmaceuticals/orphan diseases, oncology, and neurology. She has authored a variety of scientific publications, appearing in the Archives of Internal Medicine, American Journal of Managed Care, and Current Medical Research and Opinion, among others.
Dr. Sarnes received her Doctor of Pharmacy from the University of Pittsburgh School of Pharmacy. Her post-doctoral training includes an Outcomes Research Fellowship at the University of South Florida and Applied Health Outcomes. Dr. Sarnes also received a Master of Public Health in Epidemiology from the University of South Florida College of Public Health. She currently serves as adjunct faculty for the University of Pittsburgh School of Pharmacy and is a member of the International Society for Pharmacoeconomics and Outcomes Research and the American Medical Writers Association.
Kim Boswell, MD, Director, Medical Communications, Xcenda
Kimberly Boswell, MD, is a Director with the Medical Communications team in Global Health Economics and Outcomes Research (GHEOR) Scientific Consulting at Xcenda. In this role, Dr. Boswell leads and conducts national and global HEOR engagements, including formulary dossiers and global value dossiers, scientific publications, slide decks, publications strategy, and field HEOR consulting. She also has expertise in risk management and compendia analyses.
Dr. Boswell has over 10 years of experience delivering value to key healthcare stakeholders through scientific communications. Her experience crosses a broad range of therapeutic areas, including cardiology, dermatology, endocrinology, gastroenterology, hematology/oncology, neurology, ophthalmology, psychiatry, pulmonary, rheumatology, and urology. She has authored a variety of scientific publications appearing in Haemophilia, Journal of Vascular Surgery, Journal of Opioid Management, American Health & Drug Benefits, The American Journal of Pharmacy Benefits, Current Medical Research & Opinion, Drug Benefit Trends, and others.
Before joining Xcenda, Dr. Boswell was a Medical Director at a Pharmaceutical ad agency where she developed and directed content for scientific publications, medical education programs, and promotional materials. She played an integral role in the development of speakers bureau content, national and regional advisory board meetings, as well as strategic and tactical business planning.
Dr. Boswell received her Doctor of Medicine from the University of Miami School of Medicine. Her Bachelor of Science was completed at Stetson University. Dr. Boswell currently serves as adjunct faculty for the University of Florida College of Pharmacy and is a member of the American Medical Writers Association.
Who Should Attend?
Individuals interested in the development or utilization of AMCP dossiers for drugs, tests, or devices, including professionals in:
- Health Economics and Outcomes Research
- Medical Affairs
- Medical Information
- Managed Markets
- Market Access
- Healthcare Coverage and Reimbursement
Xcenda is a strategic consulting firm with more than 20 years of experience applying real-world expertise in health economics and outcomes research, reimbursement, health policy, market research, and market access strategy. We support global Pharmaceutical companies as well as emerging pre-commercialization phase firms with challenges such as developing an evidence package to optimize access in key global markets, predicting product performance, and identifying reimbursement strategies and programs to maximize patient access. From development through market maturity, Xcenda helps manufacturers identify, demonstrate, and deliver their brand’s value proposition to key healthcare stakeholders.
Xcenda is backed by a wide breadth of healthcare knowledge and partnerships through its parent company, AmerisourceBergen Corporation (NYSE: ABC), a global leader in Pharmaceutical sourcing and distribution. AmerisourceBergen drives innovative partnerships to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. For more information on Xcenda, visit http://www.xcenda.com/.